Figure 7
From: Rationale for prostaglandin I2in bone marrow oedema – from theory to application
MRI scans (T2-weighted) of two different patients with bone marrow oedema (BME) (a, c) before and (b, d) six months after iloprost application. (a, b) The BME of a 50-year-old man with chronic alcohol abuse resolved completely after iloprost infusion. (c, d) A 32-year-old woman with painful BME of the medial condylus during immunosuppressive therapy after kidney transplantation was treated with iloprost and healed within six months.